Wela Strategies, Inc. Pfizer Inc Transaction History

Wela Strategies, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$45.75 - $56.69 $335,118 - $415,254	-7,325 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$41.32 - $61.25 $9,462 - $14,026	229 Added 3.23%	7,325 $433,000
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $45,687 - $58,688	-1,164 Reduced 14.09%	7,096 $305,000
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $9,982 - $11,309	278 Added 3.48%	8,260 $323,000
Q1 2021 Apr 26, 2021	BUY	$33.49 - $37.77 $63,631 - $71,763	1,900 Added 31.24%	7,982 $289,000
Q4 2020 Jan 21, 2021	SELL	$33.47 - $42.56 $10,342 - $13,151	-309 Reduced 4.83%	6,082 $224,000
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $202,914 - $238,064	6,391 New	6,391 $235,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Wela Strategies, Inc., based on Form 13F filings with the SEC.

Stay updated on Wela Strategies, Inc. with notifications on news.